Neutropenia, Chemotherapy-Induced Febrile

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Neutropenia, Chemotherapy-Induced Febrile trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 4

NCT06616571

Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints

The goal of this real-world study is to compare the efficacy and safety of QL0605 administered 24 hours and 48 hours after chemotherapy in breast cancer patient…

China336 participantsStarted 2024-09-19

Treatment: QL0605(PEG-rhG-CSF), QL0605(PEG-rhG-CSF)

All recent trials (35 shown)

Not Yet RecruitingPhase 3

NCT07483736

Efficacy of an Empirical Treatment With Amoxicillin-clavulanate (AC) Compared to the Combination Amoxicillin-clavulanate…

The combination of amoxicillin-clavulanate (AC) and a fluoroquinolone (FQ) is currently recommended for the treatment for outpatients with hematologic malignanc…

France1,526 participantsStarted 2026-03

Treatment: amoxicillin-clavulanate, Amoxicillin-clavulanate ciprofloxacin

Not Yet RecruitingNot Applicable

NCT06697262

Impact of a Telemonitoring Device on the Occurever at Home in Children at Risk of Chemotherapy-Induced Neutropenia

The goal of this clinical trial is to evaluate the feasibility of the study, measured by the acceptability rate of patients to be recruited in a study proposing…

Location not specified30 participantsStarted 2026-05-01

Treatment: Remote temperature monitoring device, Home temperature monitoring by a nurse

Neutropenia, Chemotherapy-Induced Febrile

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints

All recent trials (35 shown)

Efficacy of an Empirical Treatment With Amoxicillin-clavulanate (AC) Compared to the Combination Amoxicillin-clavulanate…

Impact of a Telemonitoring Device on the Occurever at Home in Children at Risk of Chemotherapy-Induced Neutropenia

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints

All recent trials (35 shown)

Efficacy of an Empirical Treatment With Amoxicillin-clavulanate (AC) Compared to the Combination Amoxicillin-clavulanate…

Impact of a Telemonitoring Device on the Occurever at Home in Children at Risk of Chemotherapy-Induced Neutropenia

Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase

Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy

Prophylaxis of Febrile Neutropenia With Lactoferrin in Oncohematologic Children Undergoing Induction Chemotherapy

Comparison of G-CSF & Antibiotics Versus Antibiotics Alone in Resolution of Febrile Neutropenia

Patient Preference Between a Prefilled Syringe or a Prefilled Pen Device for Administration of Pegfilgrastim

Predictive Value of ProCalcitonin for the Detection of Bacteraemia in Patients Presenting to the Emergency Department fo…

Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer

Feasibility and Comparison of Continuously Monitored Vital Signs in Pediatric Patients With Cancer.

Shared Health Information System for Febrile Neutropenia

Evaluation of Infective Risk, Efficacy of Bacterial Prophylaxis and Validation of Sepsis Scores NEWS (National Early War…

Efficacy and Safety Study With MYL-1401H and Neulasta

Feasibility of Monitoring Health Data in Pediatric Patients Undergoing Chemotherapy

Pediatric FN Definition 2012 Bern

Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting

Safety and Effectiveness Assessment of PeGagen® (Pegfilgrastim) in the Prevention of Chemotherapy-induced FN

Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients

Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer

A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia